← Leaderboards
Joyce Ming Cao Teng
Stanford University
$311,255
Attributed
$916,515
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $397.9K · FY2014–24$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
FDA$882,015 · 1
NIH$34,500 · 1
By mechanism
R01$882,015 · 1
R13$34,500 · 1
Top collaborators
- Anna Lee Bruckner3 shared
- Anthony J Mancini3 shared
- Edda Frauke Spiekerkoetter1 shared
Most similar at Stanford University
Same institution · by research overlap
- Vinicio A De Jesus Perez$12,110,754
- Linda C Giudice$28,525,430
- Edda Frauke Spiekerkoetter$6,465,471
- Marlene Rabinovitch$40,032,014
- Joseph C Wu$80,370,369
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAmericanAnemiaAreaBasic ScienceBench To BedsideBiological SciencesBiological SystemsBiologyBloodBlood CoagulationBlood Coagulation DisordersBlood VesselsCaliforniaCardiopulmonaryCardiovascular DiseasesCardiovascular SystemCareerCareer DevelopmentCellsCellular BiologyCerebrovascularCerebrovascular Disorders3-Dimensional
Grant awards (4)
Vasculata 2024$34,500
R13 · FY2024 · HL
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations$86,773
R01 · FY2019 · FD · contact PI
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations$397,921
R01 · FY2017 · FD · contact PI
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations$397,321
R01 · FY2014 · FD · contact PI